Skip to Content
You are currently on the new version of our website. Access the old version .
CrystalsCrystals
  • Article
  • Open Access

17 January 2020

10 Pages

Co-Crystal Structures of Furosemide:Urea and Carbamazepine:Indomethacin Determined from Powder X-Ray Diffraction Data

,
,
,
and
1
School of Pharmacy, University of Reading, Reading RG6 6AD, UK
2
M2M Pharmaceuticals Ltd., Thames Valley Science Park, Reading RG2 9LH, UK
3
Nuclear Faculty, Defence Academy of the United Kingdom, HMS Sultan, Gosport PO12 3BY, UK
4
Department of Pharmacy, University of Copenhagen, Universitetsparken 2, DK-2100 Copenhagen, Denmark

Abstract

Co-crystallization is a promising approach to improving both the solubility and the dissolution rate of active pharmaceutical ingredients. Crystal structure determination from powder diffraction data plays an important role in determining co-crystal structures, especially those generated by mechanochemical means. Here, two new structures of pharmaceutical interest are reported: a 1:1 co‑crystal of furosemide with urea formed by liquid-assisted grinding and a second polymorphic form of a 1:1 co‑crystal of carbamazepine with indomethacin, formed by solvent evaporation. Energy minimization using dispersion-corrected density functional theory was used in finalizing both structures. In the case of carbamazepine:indomethacin, this energy minimization step was essential in obtaining a satisfactory final Rietveld refinement.

Article Metrics

Citations

Article Access Statistics

Multiple requests from the same IP address are counted as one view.